SBP GROUP (01177.HK): Establishes Joint Venture with Indonesia’s Tempo Scan Holding 51% Stake to Expand Innovative Drug Market in Southeast Asia

NewTimeSpace · 2026/07/27 17:00 · By Boyuan Chen

NewTimeSpace News: On 27 July, Sino Biopharmaceutical Limited (01177.HK) announced the establishment of a joint venture with Indonesia’s Tempo Scan with a 51% equity stake to develop the innovative drug market across Southeast Asia. Tempo Scan has operated in Indonesia for over 70 years with 16 production bases and 238 distribution outlets. Registration and listing procedures for the initial batch of products are underway. Indonesia’s pharmaceutical market enjoys an annual growth rate of 8%-10%.

NewTimeSpace News: On 27 July 2026, Sino Biopharmaceutical Limited (01177.HK) issued a voluntary announcement stating that the Group has entered into a joint venture agreement with PT Tempo Scan Pacific Tbk of Indonesia to set up PT TEMPO CTTQ BIOPHARMACEUTICAL INDONESIA (TCBI). Sino Biopharmaceutical will hold a 51% stake while Tempo Scan holds the remaining 49%.

The joint venture will leverage the Group’s strengths in innovative R&D and product pipeline, together with Tempo Scan’s local capabilities including manufacturing, regulatory registration, market access and nationwide distribution network in Indonesia.

Founded in 1953, Tempo Scan operates 16 production bases and 238 distribution outlets covering the whole country. The Group will provide a differentiated product portfolio covering oncology, specialist care, cardiovascular and metabolic therapies. Multiple products have obtained local regulatory approvals or are under registration review. As the largest pharmaceutical market in Southeast Asia, Indonesia boasts a population of over 278 million with an expected annual growth rate of 8%-10%.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.

Tags：

SBP GROUP 01177.HK joint venture company